首页> 外文期刊>Biochemistry and Cell Biology >Expression and bioactivity of recombinant segments of human perforin.
【24h】

Expression and bioactivity of recombinant segments of human perforin.

机译:人穿孔素重组片段的表达和生物活性。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the study was to prepare an active recombinant human perforin by comparing 5 candidate segments of human perforin. Full-length perforin, MAC1 (28-349 aa), MAC2 (166-369 aa), C-100, and N-60 of human perforin were selected as candidate active segments and designated, respectively, HP1, HP2, HP3, HP4, and HP5. The target genes were amplified by PCR and the products were individually subcloned into pGEM-T. The genes for HP1, HP2, HP3, and HP5 were subcloned into pET-DsbA, whereas pET-41a (+) was used as the expression vector of HP4. The fusion proteins were expressed in Escherichia coli BL21pLysS(DE3) and purified using nickel nitrilotriacetic acid (NTA) agarose affinity chromatography. The hemolysis microassay was used as an activity assay of fusion protein. From this study, we obtained the recombinant plasmids pGEM-T-HP1, -HP2, -HP3, -HP4 and -HP5, consisting of 1600, 960, 600, 300bp, and 180, respectively. From these recombinant plasmids, expression plasmids were successfully constructed andexpressed in E. coli BL21pLysS(DE3). The resultant fusion proteins, affinity purified using Ni-NTA, were ~80, 58, 45, 44, and 30 kDa, respectively. The recombinant proteins were assayed for activity on hemolysis. HP2 and HP5 were the only recombinant proteins that were active in hemolysis, and the hemolytic function was concentration dependent. These results demonstrate that active recombinant forms of perforin can be synthesized in a prokaryote model. The recombinant N-60 and MAC1 (28-349 aa) of human perforin have the function of forming pores. Our study provides the experimental basis for further investigation on the application of perforin.
机译:该研究的目的是通过比较人穿孔素的5个候选片段来制备活性重组人穿孔素。选择人穿孔素的全长穿孔素,MAC1(28-349氨基酸),MAC2(166-369氨基酸),C-100和N-60作为候选活性片段,分别命名为HP1,HP2,HP3,HP4和HP5。通过PCR扩增靶基因,并将产物分别亚克隆到pGEM-T中。 HP1,HP2,HP3和HP5的基因被亚克隆到pET-DsbA中,而pET-41a(+)被用作HP4的表达载体。融合蛋白在大肠杆菌BL21pLysS(DE3)中表达,并使用次氮基三乙酸镍(NTA)琼脂糖亲和层析纯化。溶血微量测定用作融合蛋白的活性测定。通过这项研究,我们获得了重组质粒pGEM-T-HP1,-HP2,-HP3,-HP4和-HP5,分别由1600、960、600、300bp和180组成。从这些重组质粒成功构建了表达质粒,并在大肠杆菌BL21pLysS(DE3)中表达。使用Ni-NTA亲和纯化得到的融合蛋白分别为〜80、58、45、44和30 kDa。分析重组蛋白的溶血活性。 HP2和HP5是仅有的在溶血中有活性的重组蛋白,溶血功能是浓度依赖性的。这些结果表明穿孔素的活性重组形式可以在原核生物模型中合成。人穿孔素的重组N-60和MAC1(28-349aa)具有形成孔的功能。本研究为进一步研究穿孔素的应用提供了实验依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号